General

Home>News>General

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating their support for rapid progress towards clinical trials for major cancers. The Nguyen’s are Australian pharmaceutical providers and are strong supporters of Cartherics.
Pictured from left to right: Thao Nguyen, Alan Trounson, Bob Moses and Luyen Nguyen.
2019-06-24T01:35:25+10:00June 24th, 2019|

Science and Technology priorities – Election 2019

MEDIA RELEASE

8 May 2019 Parties use science to set themselves apart ….

The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.

Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]

2019-05-08T04:07:34+10:00May 8th, 2019|

Miracle Elixirs

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a yearning that can cloud our judgment.

The Scientist

Apr 1, 2019

BOB GRANT Editor-in-Chief

Cancer has bedeviled humankind since long before scientists even had a word to describe the dread disease. It is therefore understandable that our ears […]

2019-04-04T03:27:36+11:00April 4th, 2019|

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.

This is not a distant vision. It is happening right here, right now. A research team, […]

2019-03-21T01:00:32+11:00March 21st, 2019|

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+11:00February 13th, 2019|

Eradicate Cancer 2020 – Next frontiers in immunotherapy

Melbourne Convention and Exhibition Centre, 25-27 March 2020

“Success Breeds Success”

The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success.

It […]

2019-07-22T04:00:07+10:00January 29th, 2019|

Meet our newest recruit

Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal.

I’ve always had an insatiable curiosity and a passion for big-picture ideas.  Growing up both my mother and grandmother had cancer.  After such an early confrontation with the absence of health — something most of us take for granted […]

2018-12-18T02:01:36+11:00December 18th, 2018|
Go to Top